The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Impact of poor-quality medicines in the ‘developing’ world
Open accessAbstract
Since our ancestors began trading several millennia ago, counterfeit and substandard medicines have been a recurring problem, with history punctuated by crises in the supply of anti-microbials, such as fake cinchona bark in the 1600s and fake quinine in the 1800s. Unfortunately this problem persists, in particular afflicting unsuspecting patients in 'developing' countries. Poor-quality drugs are a vital (but neglected) public health problem. They contribute to a 'crevasse' between the enormous effort in therapeutic research and policy decisions and implementation of good-quality medicines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Counterfeit anti-infective drugs
Newton, P. N., Green, M. D., Fernández, F. M., Day, N. P., & White, N. J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70581-3 · Cited by 348
Self-citationSubstandard medicines in resource‐poor settings: a problem that can no longer be ignored
Caudron, J. ‐., Ford, N., Henkens, M., Macé, C., Kiddle‐Monroe, R., & Pinel, J. (2008) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2008.02106.x · Cited by 332
Pharmacopoeial quality of drugs supplied by Nigerian pharmacies
Taylor, R., Shakoor, O., Behrens, R., Everard, M., Low, A., Wangboonskul, J., Reid, R., & Kolawole, J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05065-0 · Cited by 221
Newton, P. N., Fernández, F. M., Plançon, A., Mildenhall, D. C., Green, M. D., Ziyong, L., Christophel, E. M., Phanouvong, S., Howells, S., McIntosh, E., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050032 · Cited by 216
Self-citationManslaughter by Fake Artesunate in Asia—Will Africa Be Next?
Newton, P. N., McGready, R., Fernandez, F., Green, M. D., Sunjio, M., Bruneton, C., Phanouvong, S., Millet, P., Whitty, C. J. M., Talisuna, A. O., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030197 · Cited by 184
Self-citationAntimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country Study
Bate, R., Coticelli, P., Tren, R., & Attaran, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002132 · Cited by 161
Pharmacokinetic Determinants of the Window of Selection for Antimalarial Drug Resistance
Stepniewska, K., & White, N. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00903-07 · Cited by 133
Quality and stability of TB medicines: let the buyer beware!
Laing, R. O., Vrakking, H., & Fourie, B. P. (2004) · PubMed · Cited by 13
Cited by
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Ponte-Sucre, A., Gamarro, F., Dujardin, J.-C., Barrett, M. P., López-Vélez, R., García-Hernández, R., Pountain, A. W., Mwenechanya, R., & Papadopoulou, B. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006052 · Cited by 962
Ozawa, S., Evans, D. R., Bessias, S., Haynie, D. G., Yemeke, T. T., Laing, S. K., & Herrington, J. E. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.1662 · Cited by 356
Substandard and counterfeit medicines: a systematic review of the literature
Almuzaini, T., Choonara, I., & Sammons, H. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002923 · Cited by 286
Ichim, M. C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01227 · Cited by 148
Metadata
- Authors
- Newton, P. N., Green, M. D., & Fernández, F. M.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 31
- Issue
- 3
- Pages
- 99-101
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2032524882
- Cited by
- 289
- References
- 8
- FWCI
- 10.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of poor-quality medicines in the ‘developing’ world. https://app.cochat.ai/papers/10.1016/j.tips.2009.11.005
- The paper
- Newton, P. N., Green, M. D., & Fernández, F. M. (2010). Impact of poor-quality medicines in the ‘developing’ world. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2009.11.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
